-
Eltrombopag, sold
under the
brand name
Promacta among others, is a
medication used to
treat thrombocytopenia (abnormally low
platelet counts) and severe...
- (FDA) for long-term
treatment of
adult chronic ITP on
August 22, 2008.
Eltrombopag (trade name
Promacta in the US,
Revolade in the EU) is an orally-administered...
- (INN)
Elspar eltanolone (INN)
eltenac (INN)
eltoprazine (INN)
eltrombopag (INN)
eltrombopag olamine (USAN)
elucaine (INN)
Elucirem Eluracat elvitegravir...
-
require lifelong antibiotic prophyllaxis to
prevent infections.
Study of
eltrombopag, a
thrombopoietic agent used to
increase platelets in
immune thrombocytopenic...
-
thrombopoietin and then
developed thrombocytopenia.
Romiplostim and
Eltrombopag,
compounds that are
structurally different to
thrombopoietin but stimulate...
- axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib,
eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin...
- Double-blind
Study of
Ianalumab (VAY736)
Versus Placebo in
Addition to
Eltrombopag in
Patients With
Primary Immune Thrombocytopenia (ITP) Who Had an Insufficient...
-
Edaravone is
useful for
prevention and/or
therapy of
arterial wall injury.
Eltrombopag is used to
address low
blood platelet count.
Pyrazolone groups are present...
-
stimulating the
receptor for the
hormone thrombopoietin;
Romiplostim and
Eltrombopag are examples.
Thrombopoietin mimetics are a type of
thrombopoietic agents...
-
hemoglobin level or a
person not
requiring a transfusion).
Romiplostim and
eltrombopag are
thrombopoeitin receptor agonists which act on
megakaryocytes (platelet...
